Unilever is partnering with Algenuity, a start-up specialised in developing microalgae for use in consumer products, as it looks to innovate in its plant-based portfolio.
Biotech company Algenuity will work with the research and development team within Unilever’s Foods and Refreshment (F&R) division to explore ways of bringing foods made with microalgae to market.
According to Algenuity, the high chlorophyll content of chlorella vulgaris, a nutrient-rich microalgae, can make it a challenging ingredient to work with. As well as a strong green colour, chlorophyll also gives the plants a bitter taste and smell.
In its Chlorella Colours palette, Algenuity is said to have developed a technology that significantly reduces the chlorophyll content of microalgae while allowing them to retain their natural nutrients.
This reportedly opens up ‘a wealth’ of potential applications for microalgae, as a sustainable source of protein and fibre, in the food and beverage sector.
“Microalgae offer much untapped potential as a viable, climate-friendly protein alternative,” said Alejandro Amezquita, future bio-based ingredients R&D director, Unilever F&R.
“They have a significant part to play in food system transformation. We are very much looking forward to working with Algenuity to explore the possibilities of making foods that contain microalgae more mainstream.”
Andrew Spicer, CEO and founder of Algenuity, added: “We are delighted to partner with Unilever on this. Our Chlorella Colours platform provides plant-based ingredients that are sustainable, natural, non-GM and protein rich with neutral flavours.
“They are also vegan-friendly making them extremely relevant for today’s growing consumer appetite for more plant-based foods with additional functional benefits.”
By: Antonia Garrett Peel
Source: Food Bev Media
Consumer healthcare firm Haleon has appointed Tate & Lyle executive Dawn Allen as its new chief financial officer, effective 1 November 2024. Allen will succeed Tobias Hestler, who has decided to step down from the role, citing a long-term health condition, the company said.
The group said that the bottling line, which adds 6,500 square metres to the existing 60,700-square-metre site, is the next necessary stage in the company’s international development. The leading brand in Campari Group’s global sales, demand for the Italian bitter apéritif has grown by 500% in the last decade.
The partnership will see Coca-Cola adopt new technology to foster innovation and productivity globally. Through the deal, Coca-Cola has made a $1.1 billion commitment to the Microsoft Cloud and its generative AI capabilities.
